Skip to main content

Allergic Reactions News (Page 5)

Related terms: Allergic Drug Reaction, Allergic

FDA Approves Odactra for House Dust Mite Allergies

March 1, 2017 – The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced...

FDA Medwatch Alert: Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery

ISSUE: Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for...

FDA Approves Tris Pharma's New Drug Application for Karbinal ER

MONMOUTH JUNCTION, N.J., April 3, 2013 /PRNewswire/ – Tris Pharma, a specialty pharmaceutical company focused on developing innovative drug delivery technologies, today announced that the U.S. Food...

Sanofi Announces FDA Approval for Auvi-Q, First Voice-guided Epinephrine Auto-injector for Patients with Life-threatening Allergies

PARIS, Aug. 13, 2012 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) has approved Audi-Q (epinephrine injection, USP) for the emergency treatment of...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Anaphylaxis, Allergies

Related drug support groups

prednisone, Benadryl, triamcinolone, diphenhydramine, loratadine, promethazine, Phenergan, epinephrine, EpiPen, cyproheptadine